DNA Sequencing Market

2021-2030 Analysis and Review DNA Sequencing Market

DNA Sequencing Market

DNA Sequencing Market By End Users (Research Centres and Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology), By Technology (Sequencing by Synthesis, Ion Semiconductor, Sequencing by Ligation, Single-Molecule Real-Time, Single-Molecule Real-Time Sequencing), By Application (Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021 – 2030

28-02-2022 REP-HC-139290 111 pages Format

DNA sequencing market is expected to grow with a CAGR of 21.0% during the forecast period of 2021-2030. DNA sequencing is the determination of the order of four chemical buildings blocks called as the bases that are responsible for the creation of DNA molecule. The sequence carries the genetic information that is carried in the particular DNA segment. The technology is one of the fastest growing segments in the life science tools market. The technology is gaining high commercialization and is finding huge application in various end user segments such as pharmaceutical and biotechnology companies, research centers and academic & government institutes, hospital and clinics etc. 

DNA Sequencing Market

Emerging and Applied Markets in DNA Sequencing is A Key Driver

The emerging technology in the DNA sequencing market is Single-Molecule Real Time Sequencing (SMRT), which isa third generation sequencing and is developed by Pacific Biosciences. This technology involves a single-stranded molecule of deoxyribonucleic acid (DNA) which is attached to a DNA polymerase enzyme.Single-Molecule Real Time Sequencing (SMRT) is considered to be a very efficient technique as lesser expensive chemicals are used in this technique. Moreover, it is also extremely sensitive, which enables scientists to efficiently eavesdrop on deoxyribonucleic acid polymerase and detect it making a strand of deoxyribonucleic acid. It can also produceextensive reads of sequence up to 10-15 kilobases long from single molecules of deoxyribonucleic acid (DNA), very rapidly. Generating long read sequence is very essential because it is easier to accumulate genomes from longer fragments of deoxyribonucleic acid. It also means that for minute genomes the whole sequence can be achieved without the need for the time-consuming gap closing and expensive techniques that other technologies need.Moreover, using this technique scientist are now able to re-sequence genomes that have previously been sequenced to obtain a higher level of precision. For instance, using Single-Molecule Real TimeSequencing inEscherichia coli has now been sequenced to an accuracy of 99.9999 %. In addition, this sequencing technique has resulted in much more sophisticated, faster, and cheaper sequencing of the genome or DNA. 

Pharmaceutical and Biotechnology Companies Are Fastest Growing Markets

The global DNA sequencing market can be segmented on the basis of end users including research centers and academic & government institutes; hospitals & clinics; pharmaceutical & biotechnology companies; and, other end users. Amongst the various end users, research centers and academic & government institutes dominate the global DNA sequencing market in end user segment. Moreover, pharmaceutical and biotechnology companies are anticipated to grow at the highest CAGR of 22.4% during the forecast period.In healthcare sector, one of the most innovative and fast growing field is genomics, which comprises the sequencing and analysis of the human genome (complete set of DNA). Genomics is enabling the pharmaceutical companies to adopt a more personalized approach for drug development, and it is expected to lead to safer and more effective drugs. Genome testing or sequencing can identify ancestry, disease risk, traits and response to medicines, and is also helping in the development of new targeted therapies sometimes called personalized medicine.

Sequencing by Synthesis Technology Held the Largest Market Share

The global DNA sequencing market can be segregated on the basis of technologies including sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, pyrosequencing, single-molecule real-time sequencing and various other technologies. Amongst the various technologies, sequencing by synthesis technology held the largest market share of approximately 24% in 2020. Moreover, single molecule real time sequencing (SMRT) technology is anticipated to be the fastest growing technology with a CAGR of 23.2% during the forecast period. Apart from the substantial success of this technology, challenges continue to limit the capability to reduce the human genome sequencing cost to $100,000 or less. For the achievement of dramatically reduced cost along with enhanced quality and throughput require the seamless integration of technological and scientific efforts across disciplines within chemistry, biochemistry, engineering and physics. 

North America Holds the Largest Share While APAC to Grow Fast

North America has the largest share in the global market and it is driven by the presence of major key player such as Affymetrix, Inc. (U.S.); Agilent Technologies, Inc. (U.S.); Bio-Rad Laboratories, Inc. (U.S.); GE Healthcare (U.S.); Illumina, Inc. (U.S.);Qiagen N.V. (Germany); and, Thermo fisher Scientific, Inc. (U.S.). North America also accounts for the highest number of patients. n North America, the prevalence of various cancer such as breast cancer, lung and bronchus cancer, prostate cancer, colon and rectum cancer, bladder cancer, melanoma of the skin, non-Hodgkin lymphoma, thyroid cancer, kidney and renal pelvis cancer, leukemia, endometrial cancer, Pancreatic cancer, and others are growing rapidly due to which the demand for DNA sequencing is continuously increasing which is also acting as the driver for the market. In North America, the United States and Canada are contributing to the growth of the DNA sequencing market. In the United States, the prevalence rate of various cancer is very high due to which it is majorly contributing to the growth of this market in North America region. Asia Pacific is expected to be the fastest growing region with a CAGR of 21.5% during the forecast period. Large population of the India and China is suffering with diabetes and other peripheral diseases, and the prevalence of these diseases is growing at a very fast rate. The large number of diabetic patients is of young age.

Historical &Forecast Period

This research report presents the analysis of each segment from 2020 to 2030 considering 2021 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segment are calculated for the forecast period from 2021 to 2030.

Report Methodology

Market revenues and CAGR were derived from primary and secondary research. Both quantitative and qualitative trends were considered for extrapolation of market revenues. The derived market estimates were further validated from top down, bottom strategies and primary research. The scope of the market is limited to the following segments of product categories and region.


By End Users (2020-2030; US$ Mn)

Research Centres and Academic & Government Institutes

Hospitals & Clinics

Pharmaceutical & Biotechnology

Other End-Users

By Technology (2020-2030; US$ Mn)

Sequencing by Synthesis

Ion Semiconductor Sequencing

Sequencing by Ligation

Pyrosequencing

Single-Molecule Real-Time Sequencing

Other Technologies 

By Application (2020-2030; US$ Mn)

Diagnostics

Drug Discovery

Biomarker Discovery

Personalized Medicine

Agriculture & Animal Research

Other Applications 

By Region (2020-2030; US$ Mn)

North America

Europe

Asia Pacific

Latin America

Africa 

Global Impact of Covid-19 Segment (2020-2021; US$ Mn)

Pre Covid-19 situation

Post Covid-19 situation

Key questions answered in this report

  • What are the key market segments in current scenario andin the future by product categories?
  • What are the key market segments in current scenario andin the future by regions?
  • What is the key impact of Covid-19 over market revenues and market determinants in the global DNA Sequencingmarket?
  • What are the primary and secondary macro and micro factors influencing the market growth currently and during the forecast period?
  • What are the primary and secondary macro and micro factors deterring the market growth currently and during the forecast period?
  • How to overcome the current market challenges and leverage the opportunities in each of the market segment?
  • Who are the key players in the operational predictive maintenance market and what are their key product categories and strategies?
  • What are the key strategies – mergers/acquisitions/R&D/strategic partnerships etc. that companies are deploying to enhance market revenues and growth?

Select License Type

$4,600
$6,600
$13,200

Safe and Secure SSL Encrypted

Have a Question?

We will help you find what you are looking for.

Call 1-518-730-1569

Contact sales

How can we help you?

Get in touch with us or find an office closest to you.